Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Traws Pharma (TRAW) over the last 13 years, with Q3 2025 value amounting to 0.2.

  • Traws Pharma's Asset Utilization Ratio rose 113941.44% to 0.2 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2, marking a year-over-year increase of 113941.44%. This contributed to the annual value of 0.01 for FY2024, which is 3024.45% up from last year.
  • Per Traws Pharma's latest filing, its Asset Utilization Ratio stood at 0.2 for Q3 2025, which was up 113941.44% from 0.17 recorded in Q2 2025.
  • In the past 5 years, Traws Pharma's Asset Utilization Ratio ranged from a high of 0.2 in Q3 2025 and a low of 0.0 during Q4 2021
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.01 (2023), whereas its average is 0.03.
  • In the last 5 years, Traws Pharma's Asset Utilization Ratio plummeted by 9121.74% in 2021 and then soared by 126498.75% in 2025.
  • Traws Pharma's Asset Utilization Ratio (Quarter) stood at 0.0 in 2021, then soared by 38.86% to 0.01 in 2022, then skyrocketed by 67.24% to 0.01 in 2023, then soared by 46.68% to 0.01 in 2024, then surged by 1421.02% to 0.2 in 2025.
  • Its Asset Utilization Ratio stands at 0.2 for Q3 2025, versus 0.17 for Q2 2025 and 0.01 for Q1 2025.